Aalborg Universitet
... patients. Atrial fibrillation (AF) is the most common arrhythmia and often asymptomatic asymptomatic, but can be symptomatic y pt ti especially p i lly d during i g th the di dialysis ly i ttreatment. t t Furthermore , the risk of stroke increases dramatically and the mortality doubles ...
... patients. Atrial fibrillation (AF) is the most common arrhythmia and often asymptomatic asymptomatic, but can be symptomatic y pt ti especially p i lly d during i g th the di dialysis ly i ttreatment. t t Furthermore , the risk of stroke increases dramatically and the mortality doubles ...
THE CLINICAL OUTCOME AND THE INCIDENCE OF PACEMAKER
... lead to a reduction in cardiac mortality, a reduced risk of heart failure, and a better quality of life were not proven by all the clinical trials. The MOST study which followed for three years the cardiovascular mortality and morbidity in patients with DDDR cardio stimulation toward patients with V ...
... lead to a reduction in cardiac mortality, a reduced risk of heart failure, and a better quality of life were not proven by all the clinical trials. The MOST study which followed for three years the cardiovascular mortality and morbidity in patients with DDDR cardio stimulation toward patients with V ...
Drug therapy of cardiovascular diseases
... Acute myocardial infarction. Sinus tachycardia can present in more than a third of the patients with AMI but this usually decreases over time. Patients with sustained sinus tachycardia reflects a larger infarct that are more anterior with prominent left ventricular dysfunction, associated with high ...
... Acute myocardial infarction. Sinus tachycardia can present in more than a third of the patients with AMI but this usually decreases over time. Patients with sustained sinus tachycardia reflects a larger infarct that are more anterior with prominent left ventricular dysfunction, associated with high ...
Clinical characteristics, treatment and prognosis of patients with
... creatinine serum concentration ≥130.8 µmol/l; hematocrit ≤36.9 %; age ≥72 years; Glasgow Coma Scale ≤13 points, one point for each parameter is given. Generally, based on multivariate Cox regression model and the Kaplan-Meier curves, the more points (from 0 to 8) patients obtain, the risk of heart f ...
... creatinine serum concentration ≥130.8 µmol/l; hematocrit ≤36.9 %; age ≥72 years; Glasgow Coma Scale ≤13 points, one point for each parameter is given. Generally, based on multivariate Cox regression model and the Kaplan-Meier curves, the more points (from 0 to 8) patients obtain, the risk of heart f ...
Acute and Fulminant Viral Myocarditis
... damage from inflammatory cell infiltrates, cytokine activation and virus- mediated cell death More useful when high sensitivity thresholds are used Troponin T threshold of >0.1mg/mL increases sensitivity from 34% to 53% ...
... damage from inflammatory cell infiltrates, cytokine activation and virus- mediated cell death More useful when high sensitivity thresholds are used Troponin T threshold of >0.1mg/mL increases sensitivity from 34% to 53% ...
Rx for Success - Heart Attack (Myocardial Infarction) (014)
... Heart attacks are a leading cause of death in America. They result from blood vessel disease in the heart. Infarction occurs as the blood supply to an area becomes totally blocked, usually as a result of coronary artery disease. An area of partial blockage may clot (thrombose) or may rupture, causin ...
... Heart attacks are a leading cause of death in America. They result from blood vessel disease in the heart. Infarction occurs as the blood supply to an area becomes totally blocked, usually as a result of coronary artery disease. An area of partial blockage may clot (thrombose) or may rupture, causin ...
Vasopressin Trial (ACLS)
... a randomized controlled trial Lancet 2001;358:105-9 (July 14) Study Type: POEM Purpose: Are survival outcomes greater when vasopressin is used as first line treatment for cardiac arrest verses epinephrine? Study Duration: 15 month enrollment, 324 assessed, 200 randomized, 124 excluded Trial Design: ...
... a randomized controlled trial Lancet 2001;358:105-9 (July 14) Study Type: POEM Purpose: Are survival outcomes greater when vasopressin is used as first line treatment for cardiac arrest verses epinephrine? Study Duration: 15 month enrollment, 324 assessed, 200 randomized, 124 excluded Trial Design: ...
Heart Dissection Questions
... 1. Why are pig hearts used to study the anatomy of the human heart? 2. How can you tell which side of the heart is the ventral surface? 3. How many chambers are found in the mammalian heart? What other group of organisms would have this same number of chambers? 4. What is the advantage in having thi ...
... 1. Why are pig hearts used to study the anatomy of the human heart? 2. How can you tell which side of the heart is the ventral surface? 3. How many chambers are found in the mammalian heart? What other group of organisms would have this same number of chambers? 4. What is the advantage in having thi ...
VICTOZA CV Outcomes Trial Summary
... 4. Marso SP, Poulter NR, Nissen SE, et al. Design of the Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Results (LEADER) trial. Am Heart J 2013;166(5):823-30.e5. 5. Marso SP, Daniels GH, Brown-Frandsen K, et al. Protocol for: Liraglutide and cardiovascular outcomes i ...
... 4. Marso SP, Poulter NR, Nissen SE, et al. Design of the Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Results (LEADER) trial. Am Heart J 2013;166(5):823-30.e5. 5. Marso SP, Daniels GH, Brown-Frandsen K, et al. Protocol for: Liraglutide and cardiovascular outcomes i ...
Acute Decompensated Heart Failure : Medical Management
... patients, during which their likelihood of death and rehospitalization is significantly greater than for a comparable period of chronic, but stable HF 1. ADHF is the most common clinical presentation amongst acute heart failure admissions accounting for about two-thirds of cases (Figure 1). 2 This i ...
... patients, during which their likelihood of death and rehospitalization is significantly greater than for a comparable period of chronic, but stable HF 1. ADHF is the most common clinical presentation amongst acute heart failure admissions accounting for about two-thirds of cases (Figure 1). 2 This i ...
Full Text - Ibrahim Medical College
... troponin-I (cTn-I) have more adverse outcomes than that of acute heart failure with normal cTn-I level. Elevated level of serum cTn-I is a potential risk factor for acute heart failure. This study was carried out in the department of Biochemistry, Dhaka Medical College and National Institute of Card ...
... troponin-I (cTn-I) have more adverse outcomes than that of acute heart failure with normal cTn-I level. Elevated level of serum cTn-I is a potential risk factor for acute heart failure. This study was carried out in the department of Biochemistry, Dhaka Medical College and National Institute of Card ...
NURS 315/501 Bootcamp
... arteries can lead to ischemia, injury, and infarction. Compare and contrast ischemia, injury, and infarction. Describe the pathologic changes associated with MI. ...
... arteries can lead to ischemia, injury, and infarction. Compare and contrast ischemia, injury, and infarction. Describe the pathologic changes associated with MI. ...
Psychophysiological concepts of stress induced cardiomyopathy with broken heart syndrome
... polypharmacy. Mirtazapine may be an alternative with low risk of interaction and patients may welcome the sleep-inducing effect. However, weight gain and glucose tolerance should be checked regularly and could in some patients limit its use [50]. Of cause, regular ECG recordings (QTc-time) and serum ...
... polypharmacy. Mirtazapine may be an alternative with low risk of interaction and patients may welcome the sleep-inducing effect. However, weight gain and glucose tolerance should be checked regularly and could in some patients limit its use [50]. Of cause, regular ECG recordings (QTc-time) and serum ...
Synopsis
... resolved at discharge examination (9. postoperative day) it has to be followed up for further 7 days; not resolved serious adverse events at discharge examination (9. postoperative day) are followed up until the 21. postoperative day. ...
... resolved at discharge examination (9. postoperative day) it has to be followed up for further 7 days; not resolved serious adverse events at discharge examination (9. postoperative day) are followed up until the 21. postoperative day. ...
ELR Indications AHA Guidelines
... reasonable explanation and where there is no overt clinical evidence of heart disease 2. Evaluation of cardiac rhythm after initiation of an antiarrhythmic therapy, particularly when associated with a significant proarrhythmic potential 3. Evaluation of cardiac rhythm after transient AV block associ ...
... reasonable explanation and where there is no overt clinical evidence of heart disease 2. Evaluation of cardiac rhythm after initiation of an antiarrhythmic therapy, particularly when associated with a significant proarrhythmic potential 3. Evaluation of cardiac rhythm after transient AV block associ ...
clinical problems in cardiopulmonary disease
... Lipid lowering was shown to decrease significantly the incidence of death and nonfatal myocardial infarction in both primary and secondary prevention trials with no significant serious side effects compared to placebo. Furthermore, in a recent prospective trial, aggressive LDL lowering (mean level, ...
... Lipid lowering was shown to decrease significantly the incidence of death and nonfatal myocardial infarction in both primary and secondary prevention trials with no significant serious side effects compared to placebo. Furthermore, in a recent prospective trial, aggressive LDL lowering (mean level, ...
high total leukocyte count and heart failure after myocardial infarction
... hours of admission.Echocardiogram (Echo) and X-ray chest was obtained during first four days. Chi square test was applied to seek association between high total leukocyte (TLC) and heart failure. Results: Out of 200 patients, 98 (49%) remained uncomplicated and they were discharged without clinical ...
... hours of admission.Echocardiogram (Echo) and X-ray chest was obtained during first four days. Chi square test was applied to seek association between high total leukocyte (TLC) and heart failure. Results: Out of 200 patients, 98 (49%) remained uncomplicated and they were discharged without clinical ...
management of asymptomatic aortic stenosis: what is new in 2015?
... reduced left ventricular ejection fraction (<50%), very high velocity (>5 m/sec) or a high mean gradient (>60 mm Hg) or a positive exercise test identify high risk asymptomatic patients who would benefit from early aortic valve surgery. Recently, it was recognized that up to 25% of severe aortic ste ...
... reduced left ventricular ejection fraction (<50%), very high velocity (>5 m/sec) or a high mean gradient (>60 mm Hg) or a positive exercise test identify high risk asymptomatic patients who would benefit from early aortic valve surgery. Recently, it was recognized that up to 25% of severe aortic ste ...
Glossary of Cardiology Terms
... Ischemia: a decrease in the supply of oxygenated blood to vital organs or body tissue due to obstruction of blood vessels. Cardiac ischemia is marked by chest pain and may lead to tissue damage (myocardial infarction). Left Ventricular Dysfunction: when the heart is unable to maintain normal blood o ...
... Ischemia: a decrease in the supply of oxygenated blood to vital organs or body tissue due to obstruction of blood vessels. Cardiac ischemia is marked by chest pain and may lead to tissue damage (myocardial infarction). Left Ventricular Dysfunction: when the heart is unable to maintain normal blood o ...
Transesophageal Echocardiogram (TEE)
... suspected diagnosis. It’s also performed in patients who are having heart surgery to give the surgeon and anesthesia team more information to guide treatment after surgery and confirm that the surgical procedure has been successful or if additional repair is needed prior to leaving the operating roo ...
... suspected diagnosis. It’s also performed in patients who are having heart surgery to give the surgeon and anesthesia team more information to guide treatment after surgery and confirm that the surgical procedure has been successful or if additional repair is needed prior to leaving the operating roo ...
Medtronic Unveils Data Showing Feasibility of New
... Like transvenous ICD systems, the Medtronic EV-ICD is projected to have longevity of approximately 10 years and an expected device volume of approximately 33 cc. In addition to these potential benefits, the EV-ICD approach is designed to prevent the rare, but potentially serious, risks that can occu ...
... Like transvenous ICD systems, the Medtronic EV-ICD is projected to have longevity of approximately 10 years and an expected device volume of approximately 33 cc. In addition to these potential benefits, the EV-ICD approach is designed to prevent the rare, but potentially serious, risks that can occu ...
VADs - St. Peter`s Health Partners
... severity of symptoms, the causes, and the condition of the other organs. Ventricular assist devices, or VADs, have broadened the treatment options we can offer patients with advanced heart disease, by providing patients with one or more of the following: • Support until a transplant is available, • S ...
... severity of symptoms, the causes, and the condition of the other organs. Ventricular assist devices, or VADs, have broadened the treatment options we can offer patients with advanced heart disease, by providing patients with one or more of the following: • Support until a transplant is available, • S ...
VADs - St. Peter`s Hospital
... severity of symptoms, the causes, and the condition of the other organs. Ventricular assist devices, or VADs, have broadened the treatment options we can offer patients with advanced heart disease, by providing patients with one or more of the following: • Support until a transplant is available, • S ...
... severity of symptoms, the causes, and the condition of the other organs. Ventricular assist devices, or VADs, have broadened the treatment options we can offer patients with advanced heart disease, by providing patients with one or more of the following: • Support until a transplant is available, • S ...
Chapter 12 A and B questions
... potential in cardiac myofibers? How can pacemaker cells be identified electrically? What would the heart rate be if all neural and hormonal inputs were eliminated? What is an ectopic pacemaker? Which cells usually take over pacemaker functions if the AV node is defective? What events in the heart ge ...
... potential in cardiac myofibers? How can pacemaker cells be identified electrically? What would the heart rate be if all neural and hormonal inputs were eliminated? What is an ectopic pacemaker? Which cells usually take over pacemaker functions if the AV node is defective? What events in the heart ge ...